Rankings
▼
Calendar
RGEN Q4 2016 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q4 2016 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$26M
Gross Profit
$13M
52.5% margin
Operating Income
$3M
11.3% margin
Net Income
$5M
19.6% margin
EPS (Diluted)
$0.15
QoQ Revenue Growth
+3.7%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$1M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$289M
Total Liabilities
$120M
Stockholders' Equity
$169M
Cash & Equivalents
$142M
← FY 2016
All Quarters
Q1 2017 →